• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

携带超毒力表型的多重耐药肺炎克雷伯菌菌株是否应重新分类为超强毒力或超级毒力?

Should multidrug resistant Klebsiella pneumoniae strains displaying hypervirulent traits be reclassified as either ultravirulent or supervirulent?

机构信息

Nykode Therapeutics ASA, Oslo Science Park, Gaustadalléen 21, 0349 Oslo, Norway.

出版信息

Microbiol Res. 2023 Oct;275:127446. doi: 10.1016/j.micres.2023.127446. Epub 2023 Jul 5.

DOI:10.1016/j.micres.2023.127446
PMID:37422962
Abstract

Historically, Klebsiella pneumoniae isolates were described either as hypervirulent or classical. While hypervirulent strains display a precise phenotype (thicker capsule, hypermucoviscosity, absence of antibiotic resistance markers, several siderophores, etc.), classical strains can relate to all other K. pneumoniae strains, including virulent multidrug-resistant clinical isolates. Recently, many surveillance studies reported virulent K. pneumoniae nosocomial strains resistant to all antibiotic classes which also contain genetic markers associated with hypervirulence. Due to their higher virulence and clinical importance, here it is proposed reclassify them as ultravirulent and as supervirulent, to distinguish them from each other and from those with either hypervirulent or virulent phenotypes.

摘要

从历史上看,肺炎克雷伯菌的分离株被描述为高毒力或经典型。虽然高毒力菌株表现出精确的表型(较厚的荚膜、高度黏液性、缺乏抗生素耐药标志物、几种铁载体等),但经典菌株可能与所有其他肺炎克雷伯菌菌株有关,包括毒力多药耐药的临床分离株。最近,许多监测研究报告称,具有高毒力的医院获得性肺炎克雷伯菌菌株对所有抗生素类别均具有耐药性,同时还含有与高毒力相关的遗传标志物。由于其更高的毒力和临床重要性,因此建议将它们重新分类为超强毒力和超级毒力,以将它们彼此区分开来,并与具有高毒力或毒力表型的菌株区分开来。

相似文献

1
Should multidrug resistant Klebsiella pneumoniae strains displaying hypervirulent traits be reclassified as either ultravirulent or supervirulent?携带超毒力表型的多重耐药肺炎克雷伯菌菌株是否应重新分类为超强毒力或超级毒力?
Microbiol Res. 2023 Oct;275:127446. doi: 10.1016/j.micres.2023.127446. Epub 2023 Jul 5.
2
Antimicrobial Resistance of Hypervirulent : Epidemiology, Hypervirulence-Associated Determinants, and Resistance Mechanisms.高毒力 耐药性:流行病学、高毒力相关决定因素和耐药机制。
Front Cell Infect Microbiol. 2017 Nov 21;7:483. doi: 10.3389/fcimb.2017.00483. eCollection 2017.
3
The Small Protein RmpD Drives Hypermucoviscosity in Klebsiella pneumoniae.小分子蛋白 RmpD 驱动肺炎克雷伯菌的高黏液性。
mBio. 2020 Sep 22;11(5):e01750-20. doi: 10.1128/mBio.01750-20.
4
Unusual Hypermucoviscous Clinical Isolate of Klebsiella pneumoniae with No Known Determinants of Hypermucoviscosity.产异常黏液型肺炎克雷伯菌的临床分离株,其黏液表型并非由已知的超黏液型决定因素所致。
Microbiol Spectr. 2022 Jun 29;10(3):e0039322. doi: 10.1128/spectrum.00393-22. Epub 2022 Jun 1.
5
Klebsiella pneumoniae clinical isolates with features of both multidrug-resistance and hypervirulence have unexpectedly low virulence.具有多重耐药和超毒力特征的肺炎克雷伯菌临床分离株的毒力出人意料地低。
Nat Commun. 2023 Dec 2;14(1):7962. doi: 10.1038/s41467-023-43802-1.
6
Hypermucoviscosity Regulator RmpD Interacts with Wzc and Controls Capsular Polysaccharide Chain Length.高黏液调节因子 RmpD 与 Wzc 相互作用,控制荚膜多糖链长。
mBio. 2023 Jun 27;14(3):e0080023. doi: 10.1128/mbio.00800-23. Epub 2023 May 4.
7
Hypervirulent Klebsiella pneumoniae: An update on epidemiology, detection and antibiotic resistance.高毒力肺炎克雷伯菌:流行病学、检测和抗生素耐药性的最新进展。
Acta Microbiol Immunol Hung. 2023 Dec 4;70(4):278-287. doi: 10.1556/030.2023.02186. Print 2023 Dec 7.
8
Mapping the Evolution of Hypervirulent Klebsiella pneumoniae.绘制高毒力肺炎克雷伯菌的进化图谱。
mBio. 2015 Jul 21;6(4):e00630. doi: 10.1128/mBio.00630-15.
9
The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae.肺炎克雷伯菌荚膜基因表达、高黏液性和高毒力的交汇点。
Curr Opin Microbiol. 2020 Apr;54:95-102. doi: 10.1016/j.mib.2020.01.006. Epub 2020 Feb 12.
10
Identification of Two Regulators of Virulence That Are Conserved in Classical and Hypervirulent Strains.鉴定两种毒力调节因子,它们在经典和超强毒力菌株中保守存在。
mBio. 2018 Aug 7;9(4):e01443-18. doi: 10.1128/mBio.01443-18.

引用本文的文献

1
Unmasking Pediatric Asthma: Epigenetic Fingerprints and Markers of Respiratory Infections.揭开儿童哮喘的面纱:表观遗传指纹与呼吸道感染标志物
Int J Mol Sci. 2025 Aug 6;26(15):7629. doi: 10.3390/ijms26157629.
2
Phages adapt to recognize an O-antigen polysaccharide site by mutating the "backup" tail protein ORF59, enabling reinfection of phage-resistant .噬菌体通过使“备用”尾蛋白ORF59发生突变来适应识别O抗原多糖位点,从而能够再次感染具有噬菌体抗性的细菌。
Emerg Microbes Infect. 2025 Dec;14(1):2455592. doi: 10.1080/22221751.2025.2455592. Epub 2025 Feb 3.
3
Clinical and microbiological characteristics and prognosis of invasive infection caused by in the community.
社区中由……引起的侵袭性感染的临床、微生物学特征及预后 。 你提供的原文中“by ”后面似乎缺少具体内容。
Ann Med. 2025 Dec;57(1):2450526. doi: 10.1080/07853890.2025.2450526. Epub 2025 Jan 10.
4
Overexpression of caused by tandem amplification contributed to ceftazidime/avibactam resistance in hypervirulent and carbapenem-resistant .串联扩增导致的过表达有助于产超广谱β-内酰胺酶和耐碳青霉烯的 对头孢他啶/阿维巴坦的耐药性。
Emerg Microbes Infect. 2024 Dec;13(1):2426481. doi: 10.1080/22221751.2024.2426481. Epub 2024 Nov 14.
5
Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent .ST11-K47 超毒力株中 KPC-135 介导的对头孢他啶-阿维巴坦耐药的分子机制。
Emerg Microbes Infect. 2024 Dec;13(1):2361007. doi: 10.1080/22221751.2024.2361007. Epub 2024 Jun 12.